SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013604
Filing Date
2020-11-12
Accepted
2020-11-12 07:48:53
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20200930x10q.htm 10-Q 1292593
2 EX-31.1 hook-20200930ex311477e00.htm EX-31.1 9476
3 EX-31.2 hook-20200930ex312df18f3.htm EX-31.2 9455
4 EX-32.1 hook-20200930ex32194c907.htm EX-32.1 8570
  Complete submission text file 0001558370-20-013604.txt   5479026

Data Files

Seq Description Document Type Size
5 EX-101.INS hook-20200930.xml EX-101.INS 1028700
6 EX-101.SCH hook-20200930.xsd EX-101.SCH 47927
7 EX-101.CAL hook-20200930_cal.xml EX-101.CAL 45437
8 EX-101.DEF hook-20200930_def.xml EX-101.DEF 175902
9 EX-101.LAB hook-20200930_lab.xml EX-101.LAB 441561
10 EX-101.PRE hook-20200930_pre.xml EX-101.PRE 335347
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 201303422
SIC: 2834 Pharmaceutical Preparations